Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker DBI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Harvey L. Sonnenberg Director | DBI Designer Brands Inc. | Sale | 24,000 | $6.15 | $147.6K Sale | Form 4 ↗ |
| Sep 14, 2026 | Mark Haley SVP, Controller & PAO | DBI Designer Brands Inc. | Sale | 17,698 | $6.37 | $112.7K Sale | Form 4 ↗ |
| Sep 11, 2026 | Mark Haley SVP, Controller & PAO | DBI Designer Brands Inc. | Sale | 1,800 | $6.01 | $10.8K Sale | Form 4 ↗ |
| Jun 10, 2026 | Mary Turner EVP;Pres DesignerBrands Canada | DBI Designer Brands Inc. | Sale | 34,708 | $7.00 | $243.0K Sale | Form 4 ↗ |
| Dec 26, 2025 | Joanna T. Lau Director | DBI Designer Brands Inc. | Sale | 13,105 | $8.00 | $104.8K Sale | Form 4 ↗ |
| Dec 11, 2025 | Deborah L. Ferree V. Chair; Ch Product Off, Director | DBI Designer Brands Inc. | Sale | 142,277 | $8.06 | $1.1M Sale | Form 4 ↗ |
| Sep 11, 2025 | Harvey L. Sonnenberg Director | DBI Designer Brands Inc. | Sale | 50,000 | $4.52 | $226.0K Sale | Form 4 ↗ |
| Sep 10, 2025 | Mark Haley SVP, Controller and PAO | DBI Designer Brands Inc. | Sale | 11,218 | $4.80 | $53.8K Sale | Form 4 ↗ |
| Apr 8, 2025 | Mary Turner EVP;Pres DesignerBrands Canada | DBI Designer Brands Inc. | Sale | 24,543 | $2.94 | $72.2K Sale | Form 4 ↗ |
| Jan 28, 2025 | Pleasant Lake Partners LLC 10% owner | DBI Designer Brands Inc. | Sale | 30,000 | $5.47 | $164.1K Sale | Form 4 ↗ |
| Jan 28, 2025 | Pleasant Lake Partners LLC 10% owner | DBI Designer Brands Inc. | Sale | 220,000 | $5.38 | $1.2M Sale | Form 4 ↗ |
| Jan 13, 2025 | Mark Alexander Cohen | DBI Designer Brands Inc. | Buy | 10,851 | $5.28 | $57.3K Buy | Form 4 ↗ |
| Jan 10, 2025 | Mark Alexander Cohen | DBI Designer Brands Inc. | Buy | 489,149 | $5.65 | $2.8M Buy | Form 4 ↗ |
| Dec 10, 2024 | Stone House Capital Management, LLC | DBI Designer Brands Inc. | Buy | 250,000 | $5.63 | $1.4M Buy | Form 4 ↗ |
| Oct 11, 2024 | Mark Haley SVP, Controller and PAO | DBI Designer Brands Inc. | Sale | 25,787 | $6.04 | $155.8K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:16 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances